Sui Yung Chan

Collaboration Map View Statistics Email Alert RSS Feed

Full Name

Sui Yung Chan

Variants

Yung, C.S.
Chan, S.-Y.
Chan, S.Y
Sui, Y.C.
Chan, S.Y.
Chan, Sui-Yung
Yung Chan, S.

Main Affiliation

PHARMACY

Faculty

FAC OF SCIENCE

phacsy@nus.edu.sg

Refined By:

Author: Zhou, S.

Department: PHARMACY

Type: Review

Results 1-8 of 8 (Search time: 0.005 seconds).

Refman EndNote Bibtex RefWorks Excel CSV PDF Send via email

	Issue Date	Title	Author(s)
1	2005	Herb-drug interactions: A literature review	Hu, Z.; Yang, X.; Ho, P.C.L. ; Sui, Y.C. ; Heng, P.W.S. ; Chan, E. ; Duan, W.; Hwee, L.K. ; Zhou, S.
2	Oct-2005	Insights into oxazaphosphorine resistance and possible approaches to its circumvention	Zhang, J.; Tian, Q. ; Chan, S.Y. ; Duan, W.; Zhou, S.
3	2005	Mechanism-based inhibition of cytochrome P450 3A4 by therapeutic drugs	Zhou, S. ; Chan, S.Y. ; Goh, B.C. ; Chan, E. ; Duan, W. ; Huang, M.; McLeod, H.L.
4	Jul-2005	Metabolism and transport of oxazaphosphorines and the clinical implications	Zhang, J.; Tian, Q. ; Sui, Y.C. ; Shu, C.L. ; Zhou, S. ; Duan, W.; Zhu, Y.-Z.
5	Mar-2006	Monitoring drug-protein interaction	Yang, X.-X.; Hu, Z.-P.; Chan, S.Y. ; Zhou, S.-F.
6	2005	Novel agents that potentially inhibit irinotecan-induced diarrhea	Yang, X. ; Hu, Z.; Chan, S.Y. ; Chan, E. ; Goh, B.C. ; Duan, W.; Zhou, S.
7	May-2006	Pharmacokinetic mechanisms for reduced toxicity of irinotecan by coadministered thalidomide	Yang, X.-X.; Hu, Z.-P.; Chan, S.Y. ; Duan, W.; Ho, P.C.-L. ; Boelsterli, U.A.; Ng, K.-Y. ; Chan, E. ; Bian, J.-S.; Chen, Y.-Z. ; Huang, M.; Zhou, S.-F.
8	2006	Topotecan is a substrate for multidrug resistance associated protein 4	Tian, Q. ; Zhang, J.; Chan, S.Y. ; Chan, E.; Ho, P.C.-L. ; Ng, K.-Y. ; Zhu, S.-F. ; Tan, T.M.C. ; Duan, W. ; Yang, H.-Y.; Huang, M.; Zhu, Y.-Z. ; Bian, J.-S. ; Yu, Q.; Nie, Y.-Q.; Li, Q.; Wei, H.